Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736)
- 1 January 1986
- journal article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 126 (1) , 115-119
- https://doi.org/10.1111/j.1748-1716.1986.tb07794.x
Abstract
The calcium‐channel ligand, nimodipine (Bay e 9736), in submicromolar concentrations (10‐7 to 10‐5 M), enhanced the potassium (25 mM) or electrical stimulation (1 Hz, 1 ms, 180 pulses) evoked release or [3H]dopamine from rat striatal slices, while it inhibited the release of [3H]acetylcholine. Nimodipine had similar effects on slices from the cerebral cortex loaded with [3H]dopamine or [3H]acetylcholine, the electrical stimulation evoked release of the catecholamine was enhanced, while release of f3H]acetylcholine was suppressed. The data indicate that nimodipine may distinguish between Ca2+channels in dopaminergic and cholinergic nerve‐terminals. The simultaneous elevation of dopamine release and suppression of acetylcholine release may prove useful in the treatment of Parkinson's disease.Keywords
This publication has 4 references indexed in Scilit:
- Does endogenous cyclic GMP inhibit potassium stimulated 45Ca uptake by P2 fraction from rat brain?Life Sciences, 1981
- The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium-antagonistic dihydropyridines. An investigation of the mechanism of action of nimodipine.Circulation Research, 1981
- ParkinsonismPostgraduate Medicine, 1978
- Drugs Affecting Movement DisordersAnnual Review of Pharmacology, 1974